• About
  • Advertise
  • Privacy & Policy
  • Contact
Thursday, September 21, 2023
Earth-News
  • Home
  • Business
  • Entertainment
    On Stage and in a Wheelchair

    On Stage and in a Wheelchair

    Suzhou Creek, Seine Meet in First Season of Our Water

    Suzhou Creek, Seine Meet in First Season of Our Water

    China’s Web Literature Popularity Continues to Grow Overseas

    China’s Web Literature Popularity Continues to Grow Overseas

    China Can Use Big Data to Tackle Climate Health Impacts: Report

    China Can Use Big Data to Tackle Climate Health Impacts: Report

    Authorities Target Loan Agencies Over AI-Driven Phone Harassment

    Authorities Target Loan Agencies Over AI-Driven Phone Harassment

    ‘Companies need to re-assess the way they communicate about their purchase of carbon credits’: EU agrees ban on ‘climate neutral’ claims by 2026

    ‘Companies need to re-assess the way they communicate about their purchase of carbon credits’: EU agrees ban on ‘climate neutral’ claims by 2026

  • General
  • Health
  • News
    Tourists make music with wheelie bags! / German Brewery Paulaner is making the SoundTrack to Oktoberfest

    Tourists make music with wheelie bags! / German Brewery Paulaner is making the SoundTrack to Oktoberfest

    Los Angeles, CA Author Publishes Adventure Novel

    Los Angeles, CA Author Publishes Adventure Novel

    Columbus, OH Author Publishes Poetic Discussion

    Columbus, OH Author Publishes Poetic Discussion

    Valley Center, CA Author Publishes Spy Novel

    Valley Center, CA Author Publishes Spy Novel

    Gaithersburg, MD Author Publishes Philosophical Journal

    Gaithersburg, MD Author Publishes Philosophical Journal

    Select Health, an Intermountain Health Company, Joins Forces with Cost Plus Drug to Lower Rx Costs

    Select Health, an Intermountain Health Company, Joins Forces with Cost Plus Drug to Lower Rx Costs

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Tech
    Apple iPhone 15 Pro Max battery tests indicate worse endurance than the iPhone 14 Pro Max

    Apple iPhone 15 Pro Max battery tests indicate worse endurance than the iPhone 14 Pro Max

    Samsung Galaxy Tab S9 FE and Galaxy Tab S9 FE Plus designs revealed by leaked official images

    Samsung Galaxy Tab S9 FE and Galaxy Tab S9 FE Plus designs revealed by leaked official images

    Tecno Spark 10 Pro smartphone review -resolution selfie camera in a $150 USD phone

    Tecno Spark 10 Pro smartphone review -resolution selfie camera in a $150 USD phone

    Black Shark Green Ghost Gamepad launches as new “e-sports grade” controller

    Black Shark Green Ghost Gamepad launches as new “e-sports grade” controller

    New Xiaomi Redmi Projector 2 and Redmi Projector 2 Pro revealed

    New Xiaomi Redmi Projector 2 and Redmi Projector 2 Pro revealed

    Lenovo improves the displays on the ThinkPad E14 & E16, but the keyboards are getting worse

    Lenovo improves the displays on the ThinkPad E14 & E16, but the keyboards are getting worse

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
  • Home
  • Business
  • Entertainment
    On Stage and in a Wheelchair

    On Stage and in a Wheelchair

    Suzhou Creek, Seine Meet in First Season of Our Water

    Suzhou Creek, Seine Meet in First Season of Our Water

    China’s Web Literature Popularity Continues to Grow Overseas

    China’s Web Literature Popularity Continues to Grow Overseas

    China Can Use Big Data to Tackle Climate Health Impacts: Report

    China Can Use Big Data to Tackle Climate Health Impacts: Report

    Authorities Target Loan Agencies Over AI-Driven Phone Harassment

    Authorities Target Loan Agencies Over AI-Driven Phone Harassment

    ‘Companies need to re-assess the way they communicate about their purchase of carbon credits’: EU agrees ban on ‘climate neutral’ claims by 2026

    ‘Companies need to re-assess the way they communicate about their purchase of carbon credits’: EU agrees ban on ‘climate neutral’ claims by 2026

  • General
  • Health
  • News
    Tourists make music with wheelie bags! / German Brewery Paulaner is making the SoundTrack to Oktoberfest

    Tourists make music with wheelie bags! / German Brewery Paulaner is making the SoundTrack to Oktoberfest

    Los Angeles, CA Author Publishes Adventure Novel

    Los Angeles, CA Author Publishes Adventure Novel

    Columbus, OH Author Publishes Poetic Discussion

    Columbus, OH Author Publishes Poetic Discussion

    Valley Center, CA Author Publishes Spy Novel

    Valley Center, CA Author Publishes Spy Novel

    Gaithersburg, MD Author Publishes Philosophical Journal

    Gaithersburg, MD Author Publishes Philosophical Journal

    Select Health, an Intermountain Health Company, Joins Forces with Cost Plus Drug to Lower Rx Costs

    Select Health, an Intermountain Health Company, Joins Forces with Cost Plus Drug to Lower Rx Costs

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Tech
    Apple iPhone 15 Pro Max battery tests indicate worse endurance than the iPhone 14 Pro Max

    Apple iPhone 15 Pro Max battery tests indicate worse endurance than the iPhone 14 Pro Max

    Samsung Galaxy Tab S9 FE and Galaxy Tab S9 FE Plus designs revealed by leaked official images

    Samsung Galaxy Tab S9 FE and Galaxy Tab S9 FE Plus designs revealed by leaked official images

    Tecno Spark 10 Pro smartphone review -resolution selfie camera in a $150 USD phone

    Tecno Spark 10 Pro smartphone review -resolution selfie camera in a $150 USD phone

    Black Shark Green Ghost Gamepad launches as new “e-sports grade” controller

    Black Shark Green Ghost Gamepad launches as new “e-sports grade” controller

    New Xiaomi Redmi Projector 2 and Redmi Projector 2 Pro revealed

    New Xiaomi Redmi Projector 2 and Redmi Projector 2 Pro revealed

    Lenovo improves the displays on the ThinkPad E14 & E16, but the keyboards are getting worse

    Lenovo improves the displays on the ThinkPad E14 & E16, but the keyboards are getting worse

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
Earth-News
No Result
View All Result
Home Science

Study explains why certain immunotherapies don’t always work as predicted

September 18, 2023
in Science
Study explains why certain immunotherapies don’t always work as predicted
Share on FacebookShare on Twitter

Study explains why certain immunotherapies don't always work as predicted

Caption:In this colon tumor, which has a mutation that gives it a high degree of DNA mismatch repair deficiency, T cells (labeled black, green, and red) have accumulated primarily in the supportive tissues (pink regions), while very few have infiltrated tumor cells (islands surrounded by the supportive tissues). Credit: Courtesy of the researchers

This block is broken or missing. You may be missing content or you might need to enable the original module.

Cancer drugs known as checkpoint blockade inhibitors have proven effective for some cancer patients. These drugs work by taking the brakes off the body’s T cell response, stimulating those immune cells to destroy tumors.

Some studies have shown that these drugs work better in patients whose tumors have a very large number of mutated proteins, which scientists believe is because those proteins offer plentiful targets for T cells to attack. However, for at least 50 percent of patients whose tumors show a high mutational burden, checkpoint blockade inhibitors don’t work at all.

A new study from MIT reveals a possible explanation for why that is. In a study of mice, the researchers found that measuring the diversity of mutations within a tumor generated much more accurate predictions of whether the treatment would succeed than measuring the overall number of mutations.

If validated in clinical trials, this information could help doctors to better determine which patients will benefit from checkpoint blockade inhibitors.

“While very powerful in the right settings, immune checkpoint therapies are not effective for all cancer patients. This work makes clear the role of genetic heterogeneity in cancer in determining the effectiveness of these treatments,” says Tyler Jacks, the David H. Koch Professor of Biology and a member of MIT’s Koch Institute for Cancer Research.

Jacks; Peter Westcott, a former MIT postdoc in the Jacks lab who is now an assistant professor at Cold Spring Harbor Laboratory; and Isidro Cortes-Ciriano, a research group leader at EMBL’s European Bioinformatics Institute (EMBL-EBI), are the senior authors of the paper, which appears today in Nature Genetics.

Table of Contents

  • A diversity of mutations
  • Failure to activate

A diversity of mutations

Across all types of cancer, a small percentage of tumors have what is called a high tumor mutational burden (TMB), meaning they have a very large number of mutations in each cell. A subset of these tumors has defects related to DNA repair, most commonly in a repair system known as DNA mismatch repair.

Because these tumors have so many mutated proteins, they are believed to be good candidates for immunotherapy treatment, as they offer a plethora of potential targets for T cells to attack. Over the past few years, the FDA has approved a checkpoint blockade inhibitor called pembrolizumab, which activates T cells by blocking a protein called PD-1, to treat several types of tumors that have a high TMB.

However, subsequent studies of patients who received this drug found that more than half of them did not respond well or only showed short-lived responses, even though their tumors had a high mutational burden. The MIT team set out to explore why some patients respond better than others, by designing mouse models that closely mimic the progression of tumors with high TMB.

These mouse models carry mutations in genes that drive cancer development in the colon and lung, as well as a mutation that shuts down the DNA mismatch repair system in these tumors as they begin to develop. This causes the tumors to generate many additional mutations. When the researchers treated these mice with checkpoint blockade inhibitors, they were surprised to find that none of them responded well to the treatment.

“We verified that we were very efficiently inactivating the DNA repair pathway, resulting in lots of mutations. The tumors looked just like they look in human cancers, but they were not more infiltrated by T cells, and they were not responding to immunotherapy,” Westcott says.

The researchers discovered that this lack of response appears to be the result of a phenomenon known as intratumoral heterogeneity. This means that, while the tumors have many mutations, each cell in the tumor tends to have different mutations than most of the other cells. As a result, each individual cancer mutation is “subclonal,” meaning that it is expressed in a minority of cells. (A “clonal” mutation is one that is expressed in all of the cells.)

In further experiments, the researchers explored what happened as they changed the heterogeneity of lung tumors in mice. They found that in tumors with clonal mutations, checkpoint blockade inhibitors were very effective. However, as they increased the heterogeneity by mixing tumor cells with different mutations, they found that the treatment became less effective.

“That shows us that intratumoral heterogeneity is actually confounding the immune response, and you really only get the strong immune checkpoint blockade responses when you have a clonal tumor,” Westcott says.

Failure to activate

It appears that this weak T cell response occurs because the T cells simply don’t see enough of any particular cancerous protein, or antigen, to become activated, the researchers say. When the researchers implanted mice with tumors that contained subclonal levels of proteins that normally induce a strong immune response, the T cells failed to become powerful enough to attack the tumor.

“You can have these potently immunogenic tumor cells that otherwise should lead to a profound T cell response, but at this low clonal fraction, they completely go stealth, and the immune system fails to recognize them,” Westcott says. “There’s not enough of the antigen that the T cells recognize, so they’re insufficiently primed and don’t acquire the ability to kill tumor cells.”

To see if these findings might extend to human patients, the researchers analyzed data from two small clinical trials of people who had been treated with checkpoint blockade inhibitors for either colorectal or stomach cancer. After analyzing the sequences of the patients’ tumors, they found that patients’ whose tumors were more homogeneous responded better to the treatment.

“Our understanding of cancer is improving all the time, and this translates into better patient outcomes,” Cortes-Ciriano says. “Survival rates following a cancer diagnosis have significantly improved in the past 20 years, thanks to advanced research and clinical studies. We know that each patient’s cancer is different and will require a tailored approach. Personalized medicine must take into account new research that is helping us understand why cancer treatments work for some patients but not all.”

The findings also suggest that treating patients with drugs that block the DNA mismatch repair pathway, in hopes of generating more mutations that T cells could target, may not help and could be harmful, the researchers say. One such drug is now in clinical trials.

“If you try to mutate an existing cancer, where you already have many cancer cells at the primary site and others that may have disseminated throughout the body, you’re going to create a super heterogeneous collection of cancer genomes. And what we showed is that with this high intratumoral heterogeneity, the T cell response is confused and there is absolutely no response to immune checkpoint therapy,” Westcott says.

More information:
Peter M. K. Westcott et al, Mismatch repair deficiency is not sufficient to elicit tumor immunogenicity, Nature Genetics (2023). DOI: 10.1038/s41588-023-01499-4

This story is republished courtesy of MIT News (web.mit.edu/newsoffice/), a popular site that covers news about MIT research, innovation and teaching.

Citation:
Study explains why certain immunotherapies don’t always work as predicted (2023, September 17)
retrieved 18 September 2023
from https://phys.org/news/2023-09-immunotherapies-dont.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : Phys.org – https://phys.org/news/2023-09-immunotherapies-dont.html

Tags: explainssciencestudy
Previous Post

NASA joins the still controversial search for UFOs

Next Post

Texas Attorney General Paxton acquitted in impeachment trial

Apple iPhone 15 Pro Max battery tests indicate worse endurance than the iPhone 14 Pro Max

Apple iPhone 15 Pro Max battery tests indicate worse endurance than the iPhone 14 Pro Max

September 21, 2023
Samsung Galaxy Tab S9 FE and Galaxy Tab S9 FE Plus designs revealed by leaked official images

Samsung Galaxy Tab S9 FE and Galaxy Tab S9 FE Plus designs revealed by leaked official images

September 21, 2023
Tecno Spark 10 Pro smartphone review -resolution selfie camera in a $150 USD phone

Tecno Spark 10 Pro smartphone review -resolution selfie camera in a $150 USD phone

September 21, 2023
Black Shark Green Ghost Gamepad launches as new “e-sports grade” controller

Black Shark Green Ghost Gamepad launches as new “e-sports grade” controller

September 21, 2023
New Xiaomi Redmi Projector 2 and Redmi Projector 2 Pro revealed

New Xiaomi Redmi Projector 2 and Redmi Projector 2 Pro revealed

September 21, 2023
Lenovo improves the displays on the ThinkPad E14 & E16, but the keyboards are getting worse

Lenovo improves the displays on the ThinkPad E14 & E16, but the keyboards are getting worse

September 21, 2023
Samsung Galaxy S23 FE: Affordable flagship to launch with two different SoCs

Samsung Galaxy S23 FE: Affordable flagship to launch with two different SoCs

September 21, 2023
Cisco snaps up Splunk in $28bn application observability deal

Cisco snaps up Splunk in $28bn application observability deal

September 21, 2023
Cowboys’ Trevon Diggs tears ACL in practice, ‘projected’ to miss rest of 2023 NFL season

Cowboys’ Trevon Diggs tears ACL in practice, ‘projected’ to miss rest of 2023 NFL season

September 21, 2023
Week 3 Fantasy Football Wide Receiver Rankings: Puka Nacua already in the WR1 conversation

Week 3 Fantasy Football Wide Receiver Rankings: Puka Nacua already in the WR1 conversation

September 21, 2023
Partenaires
afric.info
europ.info
usa-news
lesmeilleureschaussures.fr
goodsforyoutoday.com
looktopbeauty.com
keto-diet.biz
soccernews.info
nba-news.net
sportsprblog.com compar.biz
the-best.top
bestchoices.biz
expert-plus.fr
travel-mag.info
pksportsnews.com
news-sports.org

Categories

Archives

September 2023
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
« Aug    
Earth-News.info

The Earth News is an independent English-language daily published Website from all around the World News

Browse by Category

  • Business (3,288)
  • Entertainment (3,302)
  • General (2,369)
  • Health (1,582)
  • News (3,747)
  • Science (2,565)
  • Sports (3,481)
  • Tech (2,553)

Recent News

Apple iPhone 15 Pro Max battery tests indicate worse endurance than the iPhone 14 Pro Max

Apple iPhone 15 Pro Max battery tests indicate worse endurance than the iPhone 14 Pro Max

September 21, 2023
Samsung Galaxy Tab S9 FE and Galaxy Tab S9 FE Plus designs revealed by leaked official images

Samsung Galaxy Tab S9 FE and Galaxy Tab S9 FE Plus designs revealed by leaked official images

September 21, 2023
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

Go to mobile version

Study explains why certain immunotherapies don’t always work as predicted- https://puzzlee.org   https://www.laboutiquehigh-tech-leblog.com   https://www.everythingfoodanddrink.org   https://vinsdivins.com   https://chaussuresbaskets.fr   https://batmanmagazine.com   https://scbigcats.com   https://100000-articles.com   -/- Best MILF Dating and Hookup Websites | FreeHookupsSites.com   Manchester City vs Nottingham Forest: Live stream, TV Channel, Start time and Team news   Luniquz Collier Réglable en Cuir Doux avec Clochette – Collier Chat pour Chat, Chaton, Chiot, Petit Chien(17cm-22cm)-Rouge   -*-
Fatal error: Uncaught PDOException: SQLSTATE[HY000]: General error: 2006 MySQL server has gone away in /www/wwwroot/jesuislibre.info/links2.php:52 Stack trace: #0 /www/wwwroot/jesuislibre.info/links2.php(52): PDO->query() #1 {main} thrown in /www/wwwroot/jesuislibre.info/links2.php on line 52
Study explains why certain immunotherapies don’t always work as predicted *Study explains why certain immunotherapies don’t always work as predicted